DJ AstraZeneca PLC ADR Underperforms Friday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
The AstraZeneca PLC ADR $(AZN.UK)$ rallied 1.18% to $73.95 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 2.24% to 20,650.13 and Dow Jones Industrial Average falling 1.23% to 43,588.58.
AstraZeneca PLC ADR closed 15.65% short of its 52-week high of $87.68, which the company achieved on August 30th.
The ADR underperformed when compared to some of its competitors Friday, as Eli Lilly & Co. (LLY) rose 3.01% to $762.33, Biogen Inc. (BIIB) rose 3.09% to $131.95, and Johnson & Johnson $(JNJ)$ rose 1.57% to $167.33.
Trading volume (9.7 M) eclipsed its 50-day average volume of 4.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 1, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
August 01, 2025 17:21 ET (21:21 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。